A Clinical Trial involving Endobarrier - Randomisation to Endobarrier alone Versus with Incretin analogue in SustainEd Diabesity Read more about A Clinical Trial involving Endobarrier - Randomisation to Endobarrier alone Versus with Incretin analogue in SustainEd Diabesity
Diabetes and chronic disease: a call to action for world economies Read more about Diabetes and chronic disease: a call to action for world economies
The Anna Karenina principle in Diabetes Care Read more about The Anna Karenina principle in Diabetes Care
Cardio-renal disease and diabetes: Is one a subset of the other? Read more about Cardio-renal disease and diabetes: Is one a subset of the other?
Double Diabetes Insulin Resistance in Type 1 Diabetes - Where Two Worlds Collide Read more about Double Diabetes Insulin Resistance in Type 1 Diabetes - Where Two Worlds Collide
HbA1c, weight, body mass index (BMI) and systolic blood pressure changes in the Association of British Clinical Diabetologists (ABCD) nationwide dapagliflozin audit Read more about HbA1c, weight, body mass index (BMI) and systolic blood pressure changes in the Association of British Clinical Diabetologists (ABCD) nationwide dapagliflozin audit
Jamiroquai “Virtual Insanity” Social Media and Diabetes: adjunct or adversary? part 2 Read more about Jamiroquai “Virtual Insanity” Social Media and Diabetes: adjunct or adversary? part 2
Jamiroquai “Virtual Insanity” Social Media and Diabetes: adjunct or adversary? Read more about Jamiroquai “Virtual Insanity” Social Media and Diabetes: adjunct or adversary?
Early (6 month) metabolic and body weight effects of proximal intestinal exclusion as an adjunct to GLP-1 therapy in suboptimally controlled type 2 diabetes Read more about Early (6 month) metabolic and body weight effects of proximal intestinal exclusion as an adjunct to GLP-1 therapy in suboptimally controlled type 2 diabetes
